GATA - Groupe Athena, Inc. announced today they are currently processing $64 million in customer orders and they are hopeful that this number will increase in the near term. Based on the orders in hand the company expects to be able to convert at least one half or approximately $32 million into revenue during the current fiscal year ending June 30, 2016. This would put total current year revenue projections at $75,500,000, in line with projections and provide a solid revenue base to build on for the 2017 fiscal period.
The company has set the date of April 11, before the market open, for the release of 3rd quarter financials.
The Indian pharmaceutical industry is estimated to be over $55 Billion in 2020 and is expected to experience 8% annual growth through the end of the decade. GATA has emerged as a vital component of this growth by its ability to help Indian manufacturers get their products approved by the FDA for sales in the US.
For more information on Groupe Athena, Inc. please go to www.otcmarkets.com/stock/GATA/quote or visit our corporate website at www.groupeathena.com.
